Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology

BACKGROUND: The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to lowering thrombogenicity. We report here the in vivo biocompatibility and in vitro hemocompatibility pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Starke, Robert M, Thompson, John, Pagani, Ariana, Choubey, Animesh, Wainwright, John M, Wolf, Michael F, Jahanbekam, Reza, Girdhar, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
New Devices and Techniques
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509525/
https://www.ncbi.nlm.nih.gov/pubmed/32487767
http://dx.doi.org/10.1136/neurintsurg-2020-016043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509525/
https://www.ncbi.nlm.nih.gov/pubmed/32487767
http://dx.doi.org/10.1136/neurintsurg-2020-016043

Ejemplares similares